R. M. Huber (Munich, Germany), S. Banham (Glasgow, United Kingdom)
Potential advantages of nitinol (Ultraflex) stents for tracheobronchial malignant stenoses A. Breitenbucher, T. Michael, M. Carlo (Basel, Bern, Switzerland)
| |
Clubbing regression in surgically treated lung cancer patients. A study of 34 cases J. S. Moreira, M. Hass, J. C. Felicetti (Porto Alegre, Brazil)
| |
The importance of the FEV1 for functional evaluation of lung resection size I. Kopitovic, B. Andjelic, Z. Major-Zoricic, B. Milicevic (Novi Sad, Yugoslavia)
| |
Delays in the diagnosis and treatment of lung cancer T. Ozdemir, N. Basay, B. Berktas, H. Lakadamyali, M. Berkoglu ()
| |
Clinical evaluation of patients with lung carcinoma Z. R. Nanovic, M. S. Trajcevska, L. Simonovska, O. Jotovska (Skopje, Fyrom)
| |
Clinical problems in diagnosis of lung carcinoma Z. R. Nanovic, M. S. Trajcevska, L. Simonovska, O. Jotovska (Skopje, Fyrom)
| |
Lung cancer associated with Pulmonary tubercolosis M. Nikolova, I. Zlatka (Sofia, Bulgaria)
| |
Posterior mediastinal masses in a patient with beta-thalassemia intermedia F. Kanat, F. Ozer, A. Golcuk, O. Imecik (Konya, Turkey)
| |
Bronchial pseudotumour C. Cilt, N. Petraru, M. Alexe, I. P. Stoicescu (Bucharest, Romania)
| |
A case of pulmonary hamartoma diagnosed by bronchoscopic biopsy as a part of etiologic study of bronchiectasis I. Yuksekol, A. Balkan, M. Ozkan, M. Bicak, C. Can, H. Bilgic, N. Demirci, K. Ekiz (Ankara, Turkey)
| |
Lung carcinoid tumor: endoscopic findings and bleeding at biopsy R. Garcia Lujan, E. De Miguel Poch, J. Alfaro Abreu, M. Verdugo, F. J. Montoro Zulueta, A. Lopez Encuentra, P. Martin Escribano (Madrid, Spain)
| |
Primary pulmonary artery sarcoma. Diagnostic and treatment difficulties in a case report A. S. Neves, H. Vazvelho, M. Oliveira, C. Fonseca, S. Torres, A. M. Magalhães (Vila Nova de Gaia, Lisboa, Portugal)
| |
Pleural fluid pH, LDH, total protein, albumin and glucose levels as a predictor of successful pleurodesis for patient with malignant pleural effusions H. Yildirim, M. Metintas, S. Erginel, S. Metintas, I. Ucgun, F. Alatas, M. Kolsuz (Eskisehir, Turkey)
| |
The role of thoracoscopy in the diagnosis of malignant pleural effusions (PE) B. Kaeva, A. Arsovski, T. Stefanovski, O. Jovkovski, Z. Arsovski, E. Kofkarova, K. Busletic (Skopje, Fyrom)
| |
Treatment successes with talc pleurodesis at patients (pts.) with recurrent malignant pleural effusions (PE) B. Kaeva, A. Arsovski, T. Caparevska, G. Breskovska, T. Stefanovski (Skopje, Fyrom)
| |
Diagnostic utility of pseudocholinesterase (PCHE) and cholesterol (CHOL) in separation of malignant from benign pleural effusions D. Dacic, I. Djordjevic (Yugoslavia)
| |
The role of superoxide dismutase (SOD) activity and malondialdehyde (MDA) levels in the differentiation of benign-malign pleural effusion T. U. Ciftci, Y. Guney, A. Bilgihan, F. Cimen, B. Ciftci (Ankara, Turkey)
| |
Tumor markers (TM) CEA, CYFRA 21-1,MCA and NSE in pleural effusion(PE) at malignant mezothelioma and metastatic tumor of pleura B. Kaeva, T. Stefanovski, O. Jovkovski, D. Dokic, G. Breskovska (Skopje, Fyrom)
| |
Diagnostic value of CEA, CA 549, CA 15.3 , CA 72.4 in pleural fluid and comparison with cytology F. J. Montoro Zulueta, V. Villena, R. Garcia Lujan, M. I. Verdugo, A. Lopez Encuentra, P. Martin Escribano, B. Ortuno de Solo, J. Estenoz Alfaro (Madrid, Spain)
| |
Diagnostic efficiency of pleural fluid lipid-bound sialic acid level in malignant pleural effusions G. Bektemur, F. Kanat, F. Ozer, O. Imecik (Konya, Turkey)
| |